Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Visceral Adipose Tissue Increases Stress Urinary Incontinence Symptoms in Women

Abdominal fat is linked to a higher risk for stress urinary incontinence (SUI) in women, according to a study published in the March issue of the European Journ

Children’s Activity Cubes Recalled Over Choking Hazard Risk

TUESDAY, April 21, 2026 A kid s toy designed for learning and play is being pulled from the market over safety concerns. Officials say parts of the ATOYUS Child

Tween, Teen Cannabis Use Linked to Slower Cognitive Development

Youth cannabis use between ages 9 and 17 years is associated with slower cognitive development during a time of key brain development, according to a study publ

Severe Male Fertility Impairment Tied to Increased Risk for Nonreproductive Cancers

Men with severely impaired fertility may have an increased risk for colorectal and thyroid cancer, according to a study published online Feb. 21 in the European

Longer Reproductive Span Linked to Better Cognitive Trajectories

Having a longer reproductive span is associated with better cognitive trajectories, while menopausal hormone therapy (MHT) use within 10 years of menopause is a

AACR: Fruit, Vegetable, Whole Grain Intake Up in Young Patients With Lung Cancer

Young patients with lung cancer have significantly higher fruit, vegetable, and whole grain consumption than the U.S. reference, according to a study presented

Pasithea Therapeutics Announces Grant of Rare Pediatric Disease Designation (RPDD) by FDA to PAS-004 for Treatment of Neurofibromatosis Type 1 (NF1)

Pasithea Therapeutics Corp. (NASDAQ KTTA) ( Pasithea or the Company ), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic

Phase III Study Results with Bayer’s FXIa Inhibitor Asundexian Demonstrating Substantial Reduction in Ischemic Stroke with No Increase in ISTH Major Bleeding Versus Placebo Published in New England Journal of Medicine

Berlin, April 16, 2026 Bayer today announced the publication of the full results from the global, pivotal Phase III OCEANIC-STROKE study in The New England Jour

Etavopivat is the First in a New Class of Drugs to Meet Both Co-Primary Endpoints in the Phase 3 HIBISCUS Trial, Substantially Reducing Vaso-Occlusive Crisis Events and Improving Hemoglobin Response in Sickle Cell Disease

Bagsv rd, Denmark, 20 April 2026 Novo Nordisk today announced the topline results from HIBISCUS, a pivotal phase 3 trial of once-daily oral etavopivat in adults

Tozorakimab Met Primary Endpoint in Phase III MIRANDA Trial in Patients with COPD

Positive high-level results from the pivotal Phase III MIRANDA trial showed potential first-in-class tozorakimab demonstrated a statistically significant and cl

Popular Keywords